Form 4 for CI Cigna
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-25 · accession 0001225208-22-003750 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-01 | 2022-02-25 | CI | Jones Nicole S | EVP, GC | A - Grant | $0.00 | +3,823 | 46.6K | +9% | $0 | |
| M | 2022-03-01 | 2022-02-25 | CI | Jones Nicole S | EVP, GC | F - Tax | $229.64 | -2,353 | 44.2K | -5% | -$540.3K |
| 2022-03-01 | 2022-02-28 | CI | Jones Nicole S | EVP, GC | S - Sale | $228.70 | -2,307 | 41.9K | -5% | -$527.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.01 Par Value | 2022-02-25 | A | A | 3,823 | $0.00 | 46,598 | D | — | — | (F1) The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2019-2021 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |
| 2 | Common | Common Stock, $.01 Par Value | 2022-02-25 | F | D | 837 | $229.64 | 45,761 | D | — | — | (F2) Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |
| 3 | Common | Common Stock, $.01 Par Value | 2022-02-25 | F | D | 1,516 | $229.64 | 44,245 | D | — | — | (F3) Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
| 4 | Common | Common Stock, $.01 Par Value | 2022-02-28 | S | D | 2,307 | $228.70 | 41,938 | D | — | — |